Global Endometriosis Therapies Market Size, Status and Forecast 2021-2027

子宮内膜症治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Endometriosis Therapies Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2158
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:化学、材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、子宮内膜症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ホルモン避妊薬、ゴナドトロピン放出ホルモン(Gn-RH)アゴニスト、プロゲスチン療法、アロマターゼ阻害剤)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・子宮内膜症治療の市場動向
・企業の競争状況、市場シェア
・子宮内膜症治療の種類別市場規模(ホルモン避妊薬、ゴナドトロピン放出ホルモン(Gn-RH)アゴニスト、プロゲスチン療法、アロマターゼ阻害剤)
・子宮内膜症治療の用途別市場規模(病院、クリニック、その他)
・子宮内膜症治療の北米市場規模2016-2027(アメリカ、カナダ)
・子宮内膜症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・子宮内膜症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・子宮内膜症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・子宮内膜症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AbbVie、Eli Lilly、AstraZeneca、Bayer、Astellas Pharma、Meditrina Pharmaceuticals、Pfizer、Neurocrine Biosciences、Takeda Pharmaceutical)
・結論

Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

Market Analysis and Insights: Global Endometriosis Therapies Market
The global Endometriosis Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometriosis Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometriosis Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometriosis Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometriosis Therapies market.

Global Endometriosis Therapies Scope and Market Size
Endometriosis Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormonal Contraceptives
Gonadotropin-releasingHormone(Gn-RH)Agonists
Progestin Therapy
Aromatase Inhibitors

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Contraceptives
1.2.3 Gonadotropin-releasingHormone(Gn-RH)Agonists
1.2.4 Progestin Therapy
1.2.5 Aromatase Inhibitors
1.3 Market by Application
1.3.1 Global Endometriosis Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endometriosis Therapies Market Perspective (2016-2027)
2.2 Endometriosis Therapies Growth Trends by Regions
2.2.1 Endometriosis Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometriosis Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Endometriosis Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Endometriosis Therapies Industry Dynamic
2.3.1 Endometriosis Therapies Market Trends
2.3.2 Endometriosis Therapies Market Drivers
2.3.3 Endometriosis Therapies Market Challenges
2.3.4 Endometriosis Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Therapies Players by Revenue
3.1.1 Global Top Endometriosis Therapies Players by Revenue (2016-2021)
3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Endometriosis Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Therapies Revenue
3.4 Global Endometriosis Therapies Market Concentration Ratio
3.4.1 Global Endometriosis Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Therapies Revenue in 2020
3.5 Endometriosis Therapies Key Players Head office and Area Served
3.6 Key Players Endometriosis Therapies Product Solution and Service
3.7 Date of Enter into Endometriosis Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endometriosis Therapies Breakdown Data by Type
4.1 Global Endometriosis Therapies Historic Market Size by Type (2016-2021)
4.2 Global Endometriosis Therapies Forecasted Market Size by Type (2022-2027)

5 Endometriosis Therapies Breakdown Data by Application
5.1 Global Endometriosis Therapies Historic Market Size by Application (2016-2021)
5.2 Global Endometriosis Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endometriosis Therapies Market Size (2016-2027)
6.2 North America Endometriosis Therapies Market Size by Type
6.2.1 North America Endometriosis Therapies Market Size by Type (2016-2021)
6.2.2 North America Endometriosis Therapies Market Size by Type (2022-2027)
6.2.3 North America Endometriosis Therapies Market Size by Type (2016-2027)
6.3 North America Endometriosis Therapies Market Size by Application
6.3.1 North America Endometriosis Therapies Market Size by Application (2016-2021)
6.3.2 North America Endometriosis Therapies Market Size by Application (2022-2027)
6.3.3 North America Endometriosis Therapies Market Size by Application (2016-2027)
6.4 North America Endometriosis Therapies Market Size by Country
6.4.1 North America Endometriosis Therapies Market Size by Country (2016-2021)
6.4.2 North America Endometriosis Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endometriosis Therapies Market Size (2016-2027)
7.2 Europe Endometriosis Therapies Market Size by Type
7.2.1 Europe Endometriosis Therapies Market Size by Type (2016-2021)
7.2.2 Europe Endometriosis Therapies Market Size by Type (2022-2027)
7.2.3 Europe Endometriosis Therapies Market Size by Type (2016-2027)
7.3 Europe Endometriosis Therapies Market Size by Application
7.3.1 Europe Endometriosis Therapies Market Size by Application (2016-2021)
7.3.2 Europe Endometriosis Therapies Market Size by Application (2022-2027)
7.3.3 Europe Endometriosis Therapies Market Size by Application (2016-2027)
7.4 Europe Endometriosis Therapies Market Size by Country
7.4.1 Europe Endometriosis Therapies Market Size by Country (2016-2021)
7.4.2 Europe Endometriosis Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Therapies Market Size (2016-2027)
8.2 Asia-Pacific Endometriosis Therapies Market Size by Type
8.2.1 Asia-Pacific Endometriosis Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometriosis Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometriosis Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometriosis Therapies Market Size by Application
8.3.1 Asia-Pacific Endometriosis Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometriosis Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometriosis Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometriosis Therapies Market Size by Region
8.4.1 Asia-Pacific Endometriosis Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometriosis Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endometriosis Therapies Market Size (2016-2027)
9.2 Latin America Endometriosis Therapies Market Size by Type
9.2.1 Latin America Endometriosis Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Endometriosis Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Endometriosis Therapies Market Size by Type (2016-2027)
9.3 Latin America Endometriosis Therapies Market Size by Application
9.3.1 Latin America Endometriosis Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Endometriosis Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Endometriosis Therapies Market Size by Application (2016-2027)
9.4 Latin America Endometriosis Therapies Market Size by Country
9.4.1 Latin America Endometriosis Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Endometriosis Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Therapies Market Size (2016-2027)
10.2 Middle East & Africa Endometriosis Therapies Market Size by Type
10.2.1 Middle East & Africa Endometriosis Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometriosis Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometriosis Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometriosis Therapies Market Size by Application
10.3.1 Middle East & Africa Endometriosis Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometriosis Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometriosis Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometriosis Therapies Market Size by Country
10.4.1 Middle East & Africa Endometriosis Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometriosis Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Therapies Introduction
11.1.4 AbbVie Revenue in Endometriosis Therapies Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Endometriosis Therapies Introduction
11.2.4 Eli Lilly Revenue in Endometriosis Therapies Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Therapies Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Therapies Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Endometriosis Therapies Introduction
11.4.4 Bayer Revenue in Endometriosis Therapies Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Endometriosis Therapies Introduction
11.5.4 Astellas Pharma Revenue in Endometriosis Therapies Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Meditrina Pharmaceuticals
11.6.1 Meditrina Pharmaceuticals Company Details
11.6.2 Meditrina Pharmaceuticals Business Overview
11.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Introduction
11.6.4 Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2016-2021)
11.6.5 Meditrina Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Endometriosis Therapies Introduction
11.7.4 Pfizer Revenue in Endometriosis Therapies Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Neurocrine Biosciences
11.8.1 Neurocrine Biosciences Company Details
11.8.2 Neurocrine Biosciences Business Overview
11.8.3 Neurocrine Biosciences Endometriosis Therapies Introduction
11.8.4 Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2016-2021)
11.8.5 Neurocrine Biosciences Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Endometriosis Therapies Introduction
11.9.4 Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endometriosis Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Contraceptives
Table 3. Key Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
Table 4. Key Players of Progestin Therapy
Table 5. Key Players of Aromatase Inhibitors
Table 6. Global Endometriosis Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometriosis Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometriosis Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometriosis Therapies Market Share by Regions (2016-2021)
Table 10. Global Endometriosis Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometriosis Therapies Market Share by Regions (2022-2027)
Table 12. Endometriosis Therapies Market Trends
Table 13. Endometriosis Therapies Market Drivers
Table 14. Endometriosis Therapies Market Challenges
Table 15. Endometriosis Therapies Market Restraints
Table 16. Global Endometriosis Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometriosis Therapies Market Share by Players (2016-2021)
Table 18. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2020)
Table 19. Ranking of Global Top Endometriosis Therapies Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometriosis Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Therapies Product Solution and Service
Table 23. Date of Enter into Endometriosis Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometriosis Therapies Revenue Market Share by Type (2016-2021)
Table 27. Global Endometriosis Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometriosis Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometriosis Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometriosis Therapies Revenue Market Share by Application (2016-2021)
Table 31. Global Endometriosis Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometriosis Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometriosis Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometriosis Therapies Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometriosis Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometriosis Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometriosis Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometriosis Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometriosis Therapies Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometriosis Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometriosis Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometriosis Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometriosis Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometriosis Therapies Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometriosis Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometriosis Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometriosis Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometriosis Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometriosis Therapies Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometriosis Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometriosis Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometriosis Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometriosis Therapies Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometriosis Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometriosis Therapies Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometriosis Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometriosis Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometriosis Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Endometriosis Therapies Product
Table 66. AbbVie Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Endometriosis Therapies Product
Table 71. Eli Lilly Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Endometriosis Therapies Product
Table 76. AstraZeneca Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Endometriosis Therapies Product
Table 81. Bayer Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Astellas Pharma Company Details
Table 84. Astellas Pharma Business Overview
Table 85. Astellas Pharma Endometriosis Therapies Product
Table 86. Astellas Pharma Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 87. Astellas Pharma Recent Development
Table 88. Meditrina Pharmaceuticals Company Details
Table 89. Meditrina Pharmaceuticals Business Overview
Table 90. Meditrina Pharmaceuticals Endometriosis Therapies Product
Table 91. Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 92. Meditrina Pharmaceuticals Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Endometriosis Therapies Product
Table 96. Pfizer Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Neurocrine Biosciences Company Details
Table 99. Neurocrine Biosciences Business Overview
Table 100. Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 101. Neurocrine Biosciences Recent Development
Table 102. Takeda Pharmaceutical Company Details
Table 103. Takeda Pharmaceutical Business Overview
Table 104. Takeda Pharmaceutical Endometriosis Therapies Product
Table 105. Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2016-2021) & (US$ Million)
Table 106. Takeda Pharmaceutical Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Therapies Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Contraceptives Features
Figure 3. Gonadotropin-releasingHormone(Gn-RH)Agonists Features
Figure 4. Progestin Therapy Features
Figure 5. Aromatase Inhibitors Features
Figure 6. Global Endometriosis Therapies Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Endometriosis Therapies Report Years Considered
Figure 11. Global Endometriosis Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endometriosis Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endometriosis Therapies Market Share by Regions: 2020 VS 2027
Figure 14. Global Endometriosis Therapies Market Share by Regions (2022-2027)
Figure 15. Global Endometriosis Therapies Market Share by Players in 2020
Figure 16. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Therapies Revenue in 2020
Figure 18. Global Endometriosis Therapies Revenue Market Share by Type (2016-2021)
Figure 19. Global Endometriosis Therapies Revenue Market Share by Type (2022-2027)
Figure 20. North America Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endometriosis Therapies Market Share by Type (2016-2027)
Figure 22. North America Endometriosis Therapies Market Share by Application (2016-2027)
Figure 23. North America Endometriosis Therapies Market Share by Country (2016-2027)
Figure 24. United States Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endometriosis Therapies Market Share by Type (2016-2027)
Figure 28. Europe Endometriosis Therapies Market Share by Application (2016-2027)
Figure 29. Europe Endometriosis Therapies Market Share by Country (2016-2027)
Figure 30. Germany Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endometriosis Therapies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endometriosis Therapies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endometriosis Therapies Market Share by Region (2016-2027)
Figure 40. China Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endometriosis Therapies Market Share by Type (2016-2027)
Figure 48. Latin America Endometriosis Therapies Market Share by Application (2016-2027)
Figure 49. Latin America Endometriosis Therapies Market Share by Country (2016-2027)
Figure 50. Mexico Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endometriosis Therapies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endometriosis Therapies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endometriosis Therapies Market Share by Country (2016-2027)
Figure 56. Turkey Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endometriosis Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 64. Meditrina Pharmaceuticals Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 66. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 67. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Therapies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[子宮内膜症治療の世界市場規模・現状・予測2021年-2027年] (Global Endometriosis Therapies Market Size, Status and Forecast 2021-2027 / QY21APR2158)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆